Grammidin anesthetic neo tab for the races. 18 pcs


Grammidin anesthetic neo tab for the races. 18 pcs



Active substance:
1 tablet contains: gramicidin C dihydrochloride – 3.20 mg (in terms of gramicidin S – 3.00 mg); oxybuprocaine hydrochloride – 0.20 mg; cetylpyridinium chloride monohydrate – 1.05 mg (in terms of cetylpyridinium chloride 1.00 mg) ;.
Colloidal silicon dioxide – 5.00 mg talc – 60.00 mg, 15.0 mg acesulfame potassium, mint flavor – 25.00 mg Sorbitol -1065.55 mg magnesium stearate 25.0 mg.
White round biconvex tablets with an inscription on one side of the GR.
Product form:
6 or 9 tablets in blisters of PVC film or films of PVC / polyvinylidene chloride and aluminum foil printed patent. 2,3 or 4 blisters 6 tablets or blisters 2 to 9 tablets together with instructions for use placed in a pile of cardboard.
Hypersensitivity to the components forming part of the formulation; Children under 4 years of age; pregnancy (I term).
3 mg + 0,2 mg + 1 mg
Infectious and inflammatory diseases of the oral cavity and throat: tonsillitis, pharyngitis, tonsillitis, periodontitis, gingivitis, stomatitis.
Interaction with other drugs
Grammidin® anesthetic neo enhances the effects of other antibacterial agents of local and systemic effects.
pharmachologic effect
Pharmacological group:
+ Antibiotic antiseptic + local anesthetic.
A combined preparation for the treatment of infectious and inflammatory diseases of the throat and mouth. The preparation includes an antimicrobial agent gramicidin C mestnoanesteziruyuschee (analgesic) agent – oxybuprocaine and antiseptic – cetylpyridinium chloride.
The mechanism of action of gramicidin C is associated with increased permeability of the cytoplasmic membrane of a microbial cell that gives its resistance and causes destruction of cells.
Gramicidin C has a marked antimicrobial activity against pathogens of the mouth and throat infections.
Oxybuprocaine anesthetic has local anesthetic effect on the mucous membrane of the mouth and throat. It causes a reversible blockade of proliferation and conduction of nerve impulses through the axons of nerve cells. Cetylpyridinium chloride relates to antiseptic agents. Inhibits the growth and multiplication of pathogens of oral infectious diseases.
The drug has analgesic effect, reduces inflammation, has antimicrobial action, alleviates discomfort in the throat, facilitates the swallowing when resorption causes hypersalivation, which contributes to the mechanical cleansing of the oral cavity and pharynx from microorganisms.
The drug has a local effect and practically not absorbed in the gastrointestinal tract, which determines the almost complete absence of systemic effects.
Pregnancy and breast-feeding
Do not use the drug during pregnancy (I) trimester.
Breastfeeding at the time of receiving the drug should be discontinued.
Conditions of supply of pharmacies
Without recipe.
side effects
In some cases, possible allergic reactions to components of the formulation, the temporary loss of sensation language.
Storage conditions
In the dark place at a temperature not higher than 25 ° C.
Keep out of the reach of children.
Dosing and Administration
It applies after a meal by sucking mouth without chewing. Immediately after application of the preparation should refrain from eating and drinks for 1-2 hours.
Dosage for adults and children over 12 years: 1 tablet 3-4 times a day.
The dosage for children aged 4 to 12 years: 1 tablet 1-2 times a day.
In the absence of a therapeutic effect for 7 days is recommended dosing visit to a doctor.
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg

Valenta Pharm

There are no reviews yet.

Add your review